Navigation Links
ONR lines up speakers and technologies for 2012 Naval Conference
Date:9/18/2012

ARLINGTON, Va.Dr. John P. Holdren, White House Office of Science and Technology (S&T) Policy director, will join a powerful roster of military and government leaders at the Office of Naval Research (ONR) 2012 Naval S&T Partnership Conference and ASNE Expo, officials announced Sept. 18.

Holdren, who is also assistant to President Obama for S&T and co-chair of the President's Council of Advisors on S&T, will join Vice Chief of Naval Operations Adm. Mark Ferguson; Marine Corps Commandant Gen. James F. Amos; Chief of Naval Research Rear. Adm. Matthew Klunder; and NATO Chief Scientist Maj. Gen. Albert Husniauxall scheduled to speak Oct. 22-24 during the event in Crystal City, Va.

For a full list of other confirmed speakers, see the conference's complete agenda at: http://www.onr.navy.mil/Conference-Event-ONR/science-technology-partnership/2012-partnership-conference-agenda.aspx.

In keynotes and warfighter panels, speakers will offer their perspectives on research priorities for the future of the military and the nation. The focus will be on advancing technological development in several topical areas, including: autonomy and unmanned systems; assure access to maritime battle space; information dominance; expeditionary and irregular warfare; power projection and integrated defense; platform design and survivability; power and energy; warfighter performance; and total ownership cost.

Complementing the S&T presentations, the American Society of Naval Engineers Expo (ASNE) will host displays and demonstrations, including:

  • DARwIn-OP, or Dynamic Anthropomorphic Robot with Intelligence - Open Platform, humanoid robot or "soccer bot"
  • Digital tutor
  • Flexible solar blanket
  • Virtual canine improvised explosive device-detecting demonstration
  • Stop-rotor unmanned aerial veh
    '/>"/>

Contact: Peter Vietti
onrcsc@onr.navy.mil
703-588-2167
Office of Naval Research
Source:Eurekalert

Page: 1 2

Related biology news :

1. Newly released FDA draft guidelines for biosimilar drugs to be discussed at conference
2. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
3. An early spring drives butterfly population declines
4. Canadian Journal of Cardiology publishes new atrial fibrillation guidelines
5. Declines in Caribbean coral reefs pre-date damage resulting from climate change
6. Recapitulation of the entire hepatitis C virus life in engineered mouse cell lines
7. Agricultural expert outlines path for developing nations to double food production, meet 2050 demand
8. New review outlines screening strategies for osteoporosis in young adults
9. New DataONE portal streamlines access to environmental data
10. NCEAS DataONE streamlines search and analysis of massive amounts of ecological data
11. Big horns trump smooth pickup lines every time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... researchers and patients have hoped that embryonic stem cells ... bodycould provide insight into numerous diseases perhaps even be ... by the inability to transfer research and tools from ... because human ESCs are "primed" and slightly less plastic ... Powell, and Haoyi Wang, who are scientists in the ...
(Date:7/24/2014)... Africa in mid-July 2014, as the annual fire season ... areas of increased temperatures, are heavily sprinkled across the ... Congo (northeast), and Zambia (southeast). Thick gray smoke rises ... especially in the Democratic Republic of the Congo, strong ... fire season is an annual event in this region, ...
(Date:7/24/2014)... release is available in German . ... to recognize and respond to threats to health, and ... detailed understanding of the mechanism underlying immunologic memory, however, ... have converged to support the hypothesis that the persistence ... cells with stem-cell-like potential. Until now, there was no ...
Breaking Biology News(10 mins):Whitehead Institute researchers create 'naïve' pluripotent human embryonic stem cells 2Experiments prove 'stemness' of individual immune memory cells 2Experiments prove 'stemness' of individual immune memory cells 3
... 2013 The Damon Runyon Cancer Research Foundation ... its spring 2013 Clinical Investigator Award Committee review. ... are outstanding early career physician-scientists conducting patient-oriented cancer ... of the nation,s leading scientists and clinicians. ...
... other conditions caused by malfunctions in the body,s nerve ... treat. The problem is that one medicine may help ... which drugs will work with individual patients may be ... seemingly identical neurons can behave the same even though ...
... discovered a mechanism that triggers chronic inflammation in ... today in Nature Immunology , suggest a ... the way to a new class of therapies ... diseases without crippling the immune system. Alzheimer,s, atherosclerosis ...
Cached Biology News:Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators 2Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators 3Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators 4Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators 5Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators 6Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators 7Nerve cells can work in different ways with same result 2Researchers discover new way to block inflammation 2
(Date:7/24/2014)... and synthetic processes prefer to settle into equilibriuma ... is within the realm of non-equilibrium conditions where ... in energy and phases, such as temperature fluctuations, ... humans to regulate their body temperature, airplanes to ... activity. , But even though these conditions ...
(Date:7/24/2014)... , July 24, 2014  CorMedix Inc. (NYSE ... and commercializing therapeutic products for the prevention and ... receipt of notice on July 18, 2014 from ... has accepted the CorMedix plan to regain compliance ... a result, the NYSE-MKT is continuing the Company,s ...
(Date:7/24/2014)... balances – 4 steps – One Recommendation: the web-based ... narrows down the mass of product choices to a ... , First, select the working environment, then enter the ... define the accuracy – it’s really that simple. Specifying ... to models that fit best with the customer’s industry ...
(Date:7/24/2014)... NJ (PRWEB) July 24, 2014 As ... manage numerous projects in the MENA region during 2014 ... have a preferred provider agreement with DZS to manage ... MENA region,” said Global VP of R&D and President ... has developed excellent operational practices with a focus on ...
Breaking Biology Technology:New approach to form non-equilibrium structures 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services 2
... 2011 Palatin Technologies, Inc. (NYSE Amex: PTN ) ... of shares of its common stock and warrants to purchase common ... market conditions and there can be no assurance as to whether ... actual size or terms of the offering. Roth Capital ...
... GREAT NECK, N.Y., Feb. 23, 2011 Scarguard Labs, ... of scars, psoriasis and other dermatological problems through the ... delivery system, announced today that they have received approval ... consumers throughout Canada. "We are very pleased ...
... Quanterix Corporation, a single molecule diagnostics company providing ... in vitro diagnostics markets, today announced the online publication ... Si ngle Mo lecule A rray (SiMoA™) ... straightforward measurement.  The article appears in the journal ...
Cached Biology Technology:Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants 2Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants 3Quanterix Announces Publication of Novel Method Expanding Single Molecule Detection Capability 2
... Intended Use: Vision Mount is formulated for covering tissue ... soluble OR alcohol insoluble end products. , ... ... chromogens such as Fast-Red or AEC that require an aqueous ...
... potent Rnase free Ribonuclease Inhibitor ... broad range of temperatures and ... not inhibit SP6, T7, or ... M-MLV reverse transcriptase or Taq ...
... kit, 110 to 220 V, enables ... doubles flow rates and valve capacity ... kit includes the Maximizer base unit, ... tubing kit, system cable 30, and ...
Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase...
Biology Products: